通心络胶囊与盐酸氟桂嗪治疗偏头痛的临床对比分析

Clinical Comparative Analysis of Tongxinluo and Flunarizine Treatment of Migraine

目的研究通心络胶囊与盐酸氟桂嗪治疗偏头痛的临床治疗效果。方法整群选取2012年9月—2014年5月间在该院接受治疗的偏头痛患者288例,将其随机分为观察组和对照组,两组各有患者144例。观察组患者服用通心络胶囊进行治疗;对照组患者服用盐酸氟桂嗪胶囊。治疗结束后对比两组治疗效果。结果观察组偏头痛患者治疗前评分为(17.61±1.32),治疗后评分(6.14±2.11);对照组偏头痛患者治疗前评分为(16.94±1.59),治疗后评分为(10.51±3.12),两组偏头痛患者的数据差异有统计学意义(P<0.05)。观察组144例偏头痛患者经过治疗后,治疗后效果为控制的患者有49例(34.03%),治疗总有效率为91.67%;对照组144例偏头痛患者经过治疗后,治疗后效果为控制的患者有26例(18.06%),治疗总有效率为88.19%。两组偏头痛患者在接受治疗后治疗效果差异无统计学意义(P>0.05),但观察组控制率明显优于对照组,且差异有统计学意义(P<0.05)。结论通心络胶囊与盐酸氟桂嗪对偏头痛患者均有着较好的治疗效果,但通心络胶囊综合方面优势明显,患者控显率较高,治疗后评分优于盐酸氟桂嗪。

Objective Clinical study on the therapeutic effect of Tongxinluo capsule and flunarizine in treatment of migraine. Methods Select between September 2012-May 2014 in our hospital treated 288 cases of migraine patients were randomly divided into two groups and the control group, 144 cases of patients in each group. Observed in patients taking Tongxinluo treatment;con-trol group of patients taking fluoride flunarizine hydrochloride capsules. Comparative effects of treatment, after treatment. Results Observation group migraine patients before treatment score for （17.61＆#177;1.32）, （6.14＆#177;2.11） score after treatment; migraine patients in the control group before the score was （16.94＆#177;1.59）, after treatment score was （10.51＆#177;3.12）, two groups of migraine patients have significant data difference （P〈0.05）. Observation group 144 cases of migraine patients after treatment, after treatment for a patient-controlled 49 cases （34.03%）, total effective rate was 91.67%;control group, 144 cases of migraine patients after treatment, after treatment for control there are 26 cases of patients （18.06%）, total effective rate was 88.19%. Two groups of patients with mi-graine was no significant difference （P〉0.05） after receiving therapeutic effect, but the size of the observation group control rate and effective rate than the control group, and the difference was significant （P〈0.05）. Conclusion Tongxinluo and flunarizine for migraine patients have a better therapeutic effect, but Tongxinluo comprehensive obvious advantages, significantly higher rate con-trol in patients after treatment scores than flunarizine.